Success of novel immunotherapies for renal cell carcinoma
Probiotics screening to prevent mucositis
New radiotherapy combinations for NSCLC
Cutting-edge UK trials for mesothelioma: double immuno, arginine depletion and molecular profiling
Identifying non-invasive biomarker assays for lung cancer: what is an appropriate control group?